John Bradley Sorenson - 02 May 2025 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Reporting relationship: EVP, Global Operations
Issuer ticker: BSX
Reported as of: 02 May 2025
Net transaction value: -$679,213
SEC form: 4
Accepted by SEC: 06 May 2025, 16:37:45 UTC
Prior SEC filing: 19 Feb 2025
Source filing: View source filing
Reporting owner signature: /s/ Susan Thompson, Attorney-in-Fact

Key filing fact

John Bradley Sorenson filed Form 4 for BOSTON SCIENTIFIC CORP (BSX) on 06 May 2025.

Key facts

This page summarizes John Bradley Sorenson's Form 4 filing for BOSTON SCIENTIFIC CORP (BSX).
4 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 06 May 2025, 16:37.

Change

Previous filing in this sequence was filed on 19 Feb 2025.
Current net transaction value: -$679,213.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001629277 Primary reporting owner

Sorenson John Bradley

Relationship: EVP, Global Operations
Address: 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH
Signature: /s/ Susan Thompson, Attorney-in-Fact
Signature date: 05 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BSX transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +4,204
Change %: +20%
Price: $0.000000
Shares after: 25,195
Date: 02 May 2025
Ownership: Direct
Footnotes: F1

BSX transaction

Common Stock

Tax liability

Transaction value: $201,256
Shares: -1,918
Change %: -7.6%
Price: $104.93
Shares after: 23,277
Date: 02 May 2025
Ownership: Direct

BSX transaction

Common Stock

Sale

Transaction value: $477,957
Shares: -4,572
Change %: -20%
Price: $104.54
Shares after: 18,705
Date: 05 May 2025
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BSX transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -4,204
Change %: -50%
Price: $0.000000
Shares after: 4,204
Date: 02 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,204
Exercise price
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

Footnote F2

The transaction reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 9, 2024.

Footnote F3

Shares of common stock will be issued to the reporting person in four equal annual installments beginning on May 2, 2023, the first anniversary of the date of grant.